Annual accounts
Micro Entity accounts
31/03/2027Filing deadline
- Next accounts made up to
- 30/06/2026
- Last accounts made up to
- 30/06/2025
Reference data exactly as held at Companies House.
The two filings Companies House requires every year, and where each one stands against its deadline today.
Micro Entity accounts
31/03/2027Filing deadline
Confirms the registry record is up to date
13/09/2027Filing deadline
The latest figures IPHARMA 2 LTD filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
2024: £165.30K
Total Assets
2024: £485.40K
Cash in Bank
2022: £347.47K
Total Liabilities
2024: £320.10K
Employees
2024: 10
Of the 4 measures with an earlier filing to compare against, 1 rose and 3 fell. Total liabilities moved furthest, down 121.34% on 2024. See the full financial analysis for IPHARMA 2 LTD.
The full financial record
Four ways through IPHARMA 2 LTD's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 10 | 0 |
| 2024 | 10 | 0 |
| 2023 | 10 | 0 |
| 2022 | 10 | 0 |
| 2021 | 10 | – |
Reported employee count was unchanged at 10 between 2021 and 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 29/04/2014–30/11/2018 | 8 | |
| Director | 30/11/2018–Present | 7 | |
| Secretary | 29/04/2014–30/11/2018 | 0 | |
| Secretary | 20/02/2019–Present | 0 | |
| Secretary | 20/02/2019–18/12/2023 | 0 | |
| Secretary | 22/01/2015–07/07/2017 | 0 | |
| Director | 30/11/2018–18/12/2023 | 10 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 30/06/2023–30/06/2023 | 10 | |
| 30/06/2023–Present | 10 | |
| 08/01/2017–30/11/2018 | 62 | |
| 30/06/2023–30/06/2023 | 0 | |
| 30/06/2023–Present | 7 | |
| 30/06/2023–30/06/2023 | 7 | |
| 30/06/2023–Present | 0 | |
| 30/11/2018–30/06/2023 | 0 | |
| 30/06/2023–Present | 0 |
1,381 UK companies are similar to IPHARMA 2 LTD, sharing the same company status (Active), the same industry sector and activity group (Dispensing chemist in specialised stores) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
26 Newey Road, Coventry CV2 5HA
2 Wyevale Business Park, Kings Acre, Hereford, Herefordshire HR4 7BS
1st Floor 33 George Street, Croydon CR0 1LB
1 Railway Close, Sherburn, County Durham DH6 1RN
144 Melrose Drive, St. Helen Auckland, Bishop Auckland DL14 9DN
A short description of the company, written from its Companies House record.
IPHARMA 2 LTD is a private limited company registered in the United Kingdom, based in 2-3 Hill Side Buildings, Beeston Road, Leeds LS11 6AY. Companies House classifies its business as Dispensing chemist in specialised stores. It has been on the register for 12 years 5 months.
The register currently records it as active. Its 2025 accounts report net assets of £176.87K and 10 employees.
Answered from this company's own registry record and filed figures.
Companies House records IPHARMA 2 LTD under one registered business activity: Dispensing chemist in specialised stores (47.73 - SIC 2007).
IPHARMA 2 LTD is recorded as active on the Companies House register, and has been on it since 29/04/2014.
The most recent accounts Okredo holds cover 2025 and report net assets of £176.87K, total assets of £108.54K, cash in bank of £72.80K and total liabilities of £-68.33K.
On the current registry record, accounts are due by 31/03/2027 and the next confirmation statement is due by 13/09/2027.
Companies House lists 7 officers (2 currently in post) and 9 people with significant control (4 current).